William Nicholas Haining

15PUBLICATIONS
67CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy.

Matthew P Zimmerman, Amy Y Huang, Emily K Cox

|Sep 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control.

Sarah A Weiss, Amy Y Huang, Megan E Fung

|Oct 05, 2022
When Cancer Cells Become the Enablers of an Antitumor Immune Response.

Antoni Ribas, W Nicholas Haining, Ton N M Schumacher

|Sep 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.

Juan Dubrot, Peter P Du, Sarah Kate Lane-Reticker

|Feb 18, 2022
Batf-mediated epigenetic control of effector CD8+ T cell differentiation.

Hsiao-Wei Tsao, James Kaminski, Makoto Kurachi

|Jul 27, 2021
Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

Kathleen B Yates, Pierre Tonnerre, Genevieve E Martin

Pageof 3

Frequent Collaborators

7 joint publications

Debattama R Sen

5 joint publications

Rose Al Abosy

5 joint publications

Martin W LaFleur

4 joint publications

Arlene H Sharpe